Daiwa Securities Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Buy
134,946
+10,556
+8% +$208K 0.01% 612
2025
Q4
$2.36M Buy
124,390
+19,015
+18% +$352K 0.01% 621
2025
Q3
$1.96M Buy
105,375
+21,486
+26% +$401K 0.01% 636
2025
Q2
$1.55M Buy
83,889
+2,557
+3% +$45.4K 0.01% 671
2025
Q1
$1.42M Buy
81,332
+3,057
+4% +$51.5K 0.01% 672
2024
Q4
$1.36M Buy
78,275
+87
+0.1% +$1.59K 0.01% 677
2024
Q3
$1.46M Buy
78,188
+5,921
+8% +$99.8K 0.01% 653
2024
Q2
$1.11M Sell
72,267
-2,786
-4% -$39.8K 0.01% 683
2024
Q1
$1.11M Buy
75,053
+4,756
+7% +$65.9K 0.01% 698
2023
Q4
$1M Sell
70,297
-3,526
-5% -$50.1K 0.01% 696
2023
Q3
$1.03M Buy
73,823
+2,764
+4% +$35.4K 0.01% 673
2023
Q2
$836K Buy
71,059
+455
+0.6% +$5.18K 0.01% 704
2023
Q1
$812K Buy
70,604
+7,461
+12% +$92.3K 0.01% 706
2022
Q4
$785K Sell
63,143
-1,935
-3% -$24.7K 0.01% 708
2022
Q3
$854K Buy
65,078
+560
+0.9% +$8.27K 0.01% 683
2022
Q2
$901K Sell
64,518
-3,516
-5% -$47K 0.01% 677
2022
Q1
$1.01M Buy
68,034
+688
+1% +$9.41K 0.01% 698
2021
Q4
$912K Buy
67,346
+7,987
+13% +$113K 0.01% 732
2021
Q3
$874K Buy
59,359
+2,994
+5% +$50.6K 0.01% 712
2021
Q2
$1.03M Buy
56,365
+3,249
+6% +$57.8K 0.01% 632
2021
Q1
$922K Buy
53,116
+4,100
+8% +$72.1K 0.01% 646
2020
Q4
$851K Buy
49,016
+2,400
+5% +$38.3K 0.01% 614
2020
Q3
$643K Buy
46,616
+3,440
+8% +$50.5K 0.01% 622
2020
Q2
$471K Hold
43,176
0.01% 549
2020
Q1
$471K Buy
43,176
+7,300
+20% +$135K ﹤0.01% 660
2019
Q4
$766K Buy
35,876
+2,300
+7% +$51.5K 0.01% 599
2019
Q3
$771K Buy
33,576
+3,200
+11% +$68.3K 0.01% 579
2019
Q2
$598K Buy
30,376
+1,200
+4% +$23.4K 0.01% 607
2019
Q1
$568K Buy
29,176
+1,300
+5% +$24.6K 0.01% 606
2018
Q4
$459K Buy
27,876
+900
+3% +$18.1K ﹤0.01% 619
2018
Q3
$624K Buy
26,976
+2,800
+12% +$63.4K 0.01% 594
2018
Q2
$525K Buy
24,176
+1,100
+5% +$21.5K ﹤0.01% 624
2018
Q1
$407K Buy
23,076
+3,300
+17% +$58.2K ﹤0.01% 679
2017
Q4
$371K Buy
19,776
+3,800
+24% +$75.6K ﹤0.01% 703
2017
Q3
$351K Buy
15,976
+10,076
+171% +$228K ﹤0.01% 663
2017
Q2
$142K Buy
5,900
+800
+16% +$20.3K ﹤0.01% 867
2017
Q1
$142K Sell
5,100
-1,700
-25% -$44.6K ﹤0.01% 850
2016
Q4
$166K Buy
6,800
+1,400
+26% +$32.1K ﹤0.01% 807
2016
Q3
$136K Buy
5,400
+570
+12% +$13.7K ﹤0.01% 762
2016
Q2
$99K Buy
4,830
+540
+13% +$11.3K ﹤0.01% 806
2016
Q1
$86K Buy
4,290
+2,090
+95% +$40.1K ﹤0.01% 832
2015
Q4
$45K Buy
2,200
+100
+5% +$2.11K ﹤0.01% 893
2015
Q3
$49K Buy
2,100
+100
+5% +$2.55K ﹤0.01% 882
2015
Q2
$51K Hold
2,000
﹤0.01% 911
2015
Q1
$66K Buy
2,000
+400
+25% +$13K ﹤0.01% 834
2014
Q4
$49K Buy
1,600
+300
+23% +$8.27K ﹤0.01% 830
2014
Q3
$32K Hold
1,300
﹤0.01% 844
2014
Q2
$37K Buy
1,300
+400
+44% +$11.6K ﹤0.01% 831
2014
Q1
$25K Hold
900
﹤0.01% 847
2013
Q4
$24K Sell
900
-100
-10% -$2.58K ﹤0.01% 841
2013
Q3
$23K Hold
1,000
﹤0.01% 850
2013
Q2
$26K Buy
+1,000
New +$28.9K ﹤0.01% 846

Other funds holding SBRA